Brian Schwartz
Chief Tech/Sci/R&D Officer at INTENSITY THERAPEUTICS, INC.
Net worth: 46 596 $ as of 31/05/2024
Brian Schwartz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 01/12/2020 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 17/12/2020 | - |
| Chief Tech/Sci/R&D Officer | 25/01/2024 | - | |
| Independent Dir/Board Member | 17/12/2020 | 25/01/2024 | |
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Brian Schwartz
Former positions of Brian Schwartz
| Companies | Position | Start | End |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 07/09/2021 | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Director/Board Member | 01/10/2020 | 10/11/2022 |
| VINCERX PHARMA, INC. | Director/Board Member | 05/03/2020 | 23/12/2020 |
| Independent Dir/Board Member | 05/03/2020 | 23/12/2020 | |
| ARQULE, INC. | Chief Tech/Sci/R&D Officer | 01/06/2008 | 01/03/2020 |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2008 | - |
| General Counsel | 01/01/2008 | - |
Training of Brian Schwartz
| University of Pretoria | Doctorate Degree |
Statistics
International
| United States | 7 |
| South Africa | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Brian Schwartz
- Experience
